Literature DB >> 15388444

Caspofungin uptake is mediated by a high-affinity transporter in Candida albicans.

Padmaja Paderu1, Steven Park, David S Perlin.   

Abstract

The uptake of the echinocandin drug caspofungin acetate in Candida albicans was evaluated at drug levels at or near the MIC for the organism. Maximal uptake was achieved in 10 min and was energy independent. A saturable transport system, consistent with a facilitated-diffusion carrier, was observed with the unlabeled drug competing with the labeled drug for uptake and efflux. More than 90% of the transported drug was observed in a single kinetic compartment that was available for efflux, indicating that the drug was free in the cytoplasm following uptake. Efflux was also energy independent but was sensitive to the presence of a fully loaded carrier on both faces of the bilayer. Overall, the data presented are consistent with the presence of a high-affinity facilitated-diffusion transporter that mediates caspofungin uptake and could be a potential source of transport-related reduced susceptibility.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15388444      PMCID: PMC521903          DOI: 10.1128/AAC.48.10.3845-3849.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

Review 1.  Fungal beta(1,3)-D-glucan synthesis.

Authors:  C M Douglas
Journal:  Med Mycol       Date:  2001       Impact factor: 4.076

2.  Molecular cloning and characterization of a glucan synthase gene from the human pathogenic fungus Paracoccidioides brasiliensis.

Authors:  M Pereira; M S Felipe; M M Brígido; C M Soares; M O Azevedo
Journal:  Yeast       Date:  2000-03-30       Impact factor: 3.239

3.  Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in beta-1,3-glucan synthesis.

Authors:  T Mio; M Adachi-Shimizu; Y Tachibana; H Tabuchi; S B Inoue; T Yabe; T Yamada-Okabe; M Arisawa; T Watanabe; H Yamada-Okabe
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

4.  Molecular characterization of the plasma membrane H(+)-ATPase, an antifungal target in Cryptococcus neoformans.

Authors:  P Soteropoulos; T Vaz; R Santangelo; P Paderu; D Y Huang; M J Tamás; D S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

5.  Aspergillus nidulans is frequently resistant to amphotericin B.

Authors:  D P Kontoyiannis; R E Lewis; G S May; N Osherov; M G Rinaldi
Journal:  Mycoses       Date:  2002-11       Impact factor: 4.377

6.  Isolation of a gene involved in 1,3-beta-glucan synthesis in Aspergillus nidulans and purification of the corresponding protein.

Authors:  R Kelly; E Register; M J Hsu; M Kurtz; J Nielsen
Journal:  J Bacteriol       Date:  1996-08       Impact factor: 3.490

7.  A glucan synthase FKS1 homolog in cryptococcus neoformans is single copy and encodes an essential function.

Authors:  J R Thompson; C M Douglas; W Li; C K Jue; B Pramanik; X Yuan; T H Rude; D L Toffaletti; J R Perfect; M Kurtz
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

8.  Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae.

Authors:  Ameeta K Agarwal; P David Rogers; Scott R Baerson; Melissa R Jacob; Katherine S Barker; John D Cleary; Larry A Walker; Dale G Nagle; Alice M Clark
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

9.  Human salivary histatin 5 causes disordered volume regulation and cell cycle arrest in Candida albicans.

Authors:  Didi Baev; Xuewei S Li; Jin Dong; Peter Keng; Mira Edgerton
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

10.  The Candida albicans Cdr2p ATP-binding cassette (ABC) transporter confers resistance to caspofungin.

Authors:  Manuela Schuetzer-Muehlbauer; Birgit Willinger; Gerd Krapf; Sabine Enzinger; Elisabeth Presterl; Karl Kuchler
Journal:  Mol Microbiol       Date:  2003-04       Impact factor: 3.501

View more
  13 in total

1.  Serum differentially alters the antifungal properties of echinocandin drugs.

Authors:  Padmaja Paderu; Guillermo Garcia-Effron; Sergey Balashov; Guillaume Delmas; Steven Park; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2007-04-09       Impact factor: 5.191

2.  Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae.

Authors:  Florence Chapeland-Leclerc; Julien Bouchoux; Abdelhak Goumar; Christiane Chastin; Jean Villard; Thierry Noël
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

3.  Predicting community dynamics of antibiotic-sensitive and -resistant species in fluctuating environments.

Authors:  Olga A Nev; Alys Jepson; Robert E Beardmore; Ivana Gudelj
Journal:  J R Soc Interface       Date:  2020-05-27       Impact factor: 4.118

4.  Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.

Authors:  K Niimi; K Maki; F Ikeda; A R Holmes; E Lamping; M Niimi; B C Monk; R D Cannon
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 5.  Echinocandin antifungal drugs in fungal infections: a comparison.

Authors:  Sharon C-A Chen; Monica A Slavin; Tania C Sorrell
Journal:  Drugs       Date:  2011-01-01       Impact factor: 9.546

Review 6.  Caspofungin: a review of its use in the treatment of fungal infections.

Authors:  Paul L McCormack; Caroline M Perry
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Comparative Pharmacodynamics of Echinocandins against Aspergillus fumigatus Using an In Vitro Pharmacokinetic/Pharmacodynamic Model That Correlates with Clinical Response to Caspofungin Therapy: Is There a Place for Dose Optimization?

Authors:  Maria Siopi; David S Perlin; Maiken C Arendrup; Spyros Pournaras; Joseph Meletiadis
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

8.  Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins.

Authors:  Marybeth A Maligie; Claude P Selitrennikoff
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

9.  Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serum.

Authors:  Antigoni Elefanti; Johan W Mouton; Katerina Krompa; Rafal Al-Saigh; Paul E Verweij; Loukia Zerva; Joseph Meletiadis
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

10.  The Ssk1p response regulator and Chk1p histidine kinase mutants of Candida albicans are hypersensitive to fluconazole and voriconazole.

Authors:  Neeraj Chauhan; Michael Kruppa; Richard Calderone
Journal:  Antimicrob Agents Chemother       Date:  2007-07-30       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.